Transjugular intrahepatic portosystemic shunt is effective in patients with chronic portal vein thrombosis and variceal bleeding

Kumar, 2015, Review article: portal vein obstruction–epidemiology, pathogenesis, natural history, prognosis and treatment, Aliment Pharmacol Ther, 41, 276, 10.1111/apt.13019 Primignani, 2010, Portal vein thrombosis, revisited, Dig Liver Dis, 42, 163, 10.1016/j.dld.2009.08.003 Qi, 2014, Management of portal vein thrombosis in liver cirrhosis, Nat Rev Gastroenterol Hepatol, 11, 435, 10.1038/nrgastro.2014.36 Garcia-Pagán, 2008, Extrahepatic portal vein thrombosis, Semin Liver Dis, 28, 282, 10.1055/s-0028-1085096 Valla, 2002, Spectrum of portal vein thrombosis in the West, J Gastroenterol Hepatol, 17, S224, 10.1046/j.1440-1746.17.s3.4.x Klopfenstein, 2000, Cavernous transformation of the portal vein: a cause of thrombocytopenia and splenomegaly, Clin Pediatr Phila, 39, 727, 10.1177/000992280003901209 2016, Clinical practice guidelines: vascular diseases of the liver, J Hepatol, 64, 179, 10.1016/j.jhep.2015.07.040 de Franchis, 2015, Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022 Tripathi, 2015, U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients, Gut, 64, 1680, 10.1136/gutjnl-2015-309262 Shashidhar, 1999, Propranolol in prevention of portal hypertensive hemorrhage in children: a pilot study, J Pediatr Gastroenterol Nutr, 29, 12, 10.1097/00005176-199907000-00007 Kockerling, 2019, Current and future pharmacological therapies for managing cirrhosis and its complications, World J Gastroenterol, 25, 888, 10.3748/wjg.v25.i8.888 Zacharias, 2018, Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices, Cochrane Database Syst Rev, 10 Perarnau, 2010, Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis, Eur J Gastroenterol Hepatol, 22, 1093, 10.1097/MEG.0b013e328338d995 Senzolo, 2006, Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation, Aliment Pharmacol Ther, 23, 767, 10.1111/j.1365-2036.2006.02820.x Radosevich, 1993, Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion, Radiology, 186, 523, 10.1148/radiology.186.2.8421759 Luo, 2015, Advanced cirrhosis combined with portal vein thrombosis: a randomized trial of TIPS versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding, Radiology, 276, 286, 10.1148/radiol.15141252 Lv, 2018, Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial, Gut, 67, 2156, 10.1136/gutjnl-2017-314634 Qi, 2012, Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis, Med Sci Monit, 18, HY37, 10.12659/MSM.883252 Wang, 2017, Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein, Sci Rep, 7, 10868, 10.1038/s41598-017-11455-y Luca, 2011, Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis, Gut, 60, 846, 10.1136/gut.2010.228023 Jourabchi, 2013, TIPS placement via combined transjugular and transhepatic approach for cavernous portal vein occlusion: targeted approach, Case Rep Radiol, 2013 Han, 2011, Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis, J Hepatol, 54, 78, 10.1016/j.jhep.2010.06.029 Rodrigues, 2019, Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis, Aliment Pharmacol Ther, 49, 20, 10.1111/apt.15044 Yerdel, 2000, Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome, Transplantation, 69, 1873, 10.1097/00007890-200005150-00023 Li, 2019, Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival, J Dig Dis, 20, 89, 10.1111/1751-2980.12702 Bureau, 2007, Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study, Liver Int, 27, 742, 10.1111/j.1478-3231.2007.01522.x Vilstrup, 2014, Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver, Hepatology, 60, 715, 10.1002/hep.27210 Sarin, 2006, Consensus on extra-hepatic portal vein obstruction, Liver Int, 26, 512, 10.1111/j.1478-3231.2006.01269.x Rosenqvist, 2016, Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver, Acta Radiol, 57, 572, 10.1177/0284185115595060 Jiang, 2004, Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis, World J Gastroenterol, 10, 1881, 10.3748/wjg.v10.i13.1881 Han, 2009, Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation, Zhonghua Yi Xue Za Zhi, 89, 1549 Fanelli, 2011, Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma, Dig Liver Dis, 43, 78, 10.1016/j.dld.2010.06.001 Qi, 2012, Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients, Dig Dis Sci, 57, 1072, 10.1007/s10620-011-1975-5 Luo, 2014, Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension in noncirrhotic patients with portal cavernoma, Gastroenterol Res Pract, 2014, 10.1155/2014/659726 Qi, 2016, Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study, Liver Int, 36, 667, 10.1111/liv.12929 Tuite, 2007, Percutaneous transsplenic access in the management of bleeding varices from chronic portal vein thrombosis, J Vasc Interv Radiol, 18, 1571, 10.1016/j.jvir.2007.08.009 Van Ha, 2006, Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis, Cardiovasc Intervent Radiol, 29, 785, 10.1007/s00270-005-0090-4 Bilbao, 2004, Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients, Cardiovasc Intervent Radiol, 27, 474, 10.1007/s00270-004-0241-z Stein, 1999, Symptomatic spleno-mesenteric-portal venous thrombosis: recanalization and reconstruction with endovascular stents, J Vasc Interv Radiol, 10, 363, 10.1016/S1051-0443(99)70044-8 Bureau, 2004, Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study, Gastroenterology, 126, 469, 10.1053/j.gastro.2003.11.016 Rossi, 2004, Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience, Radiology, 231, 820, 10.1148/radiol.2313030349 Cejna, 2001, Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis, Radiology, 221, 437, 10.1148/radiol.2212010195 Riggio, 2010, Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial, J Hepatol, 53, 267, 10.1016/j.jhep.2010.02.033 Thalheimer, 2009, Heparin effect on thromboelastography after transjugular intrahepatic portosystemic shunt procedure, Scand J Gastroenterol, 44, 1463, 10.3109/00365520903342174 Li, 2018, Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein, Hepatobiliary Pancreat Dis Int, 17, 517, 10.1016/j.hbpd.2018.09.008 Tian, 2013, Percutaneous transhepatic variceal embolization with cyanoacrylate vs. transjugular intrahepatic portal systematic shunt for esophageal variceal bleeding, Hepatol Int, 7, 636, 10.1007/s12072-013-9433-4 Lautt, 2007, Regulatory processes interacting to maintain hepatic blood flow constancy: vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction, Hepatol Res, 37, 891, 10.1111/j.1872-034X.2007.00148.x